BLFS BioLife Solutions, Inc.
BioLife Solutions, Inc. (BLFS) is expected to report earnings on November 5, 2026, after the market close. The consensus earnings estimate is $0.01 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +2.3% since its last earnings release on August 6, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About BioLife Solutions, Inc.
BioLife Solutions Inc offers patented biopreservation media products, generic formulations of blood stem cell freezing media products, custom product formulation packaging services, and contract aseptic manufacturing formulation.
Sector
Healthcare
Industry
Medical Instruments/Supply